Turnstone Biologics (TSBX) Institutional Ownership $0.49 +0.03 (+6.41%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Turnstone Biologics (NASDAQ:TSBX)CurrentInstitutional OwnershipPercentage52.51%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$506.41KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.62M Get TSBX Insider Trade Alerts Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TSBX Institutional Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Turnstone Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Point72 Asset Management L.P.932,226$519K0.0%-16.7%4.030% 11/13/2024 FMR LLC1,172,987$653K0.0%+3.3%5.071% 8/19/2024 Point72 Asset Management L.P.1,118,588$2.93M0.0%-5.5%4.837% 8/13/2024 Sei Investments Co.11,882$31K0.0%N/A0.051% 5/17/2024 Zimmer Partners LP179,026$469K0.0%+271.4%0.774% 4/17/2024 Kathleen S. Wright Associates Inc.42,553$111K0.1%N/A0.184% 2/15/2024 PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742% 2/15/2024 Caas Capital Management LP45,831$117K0.0%-40.1%0.198% 12/6/2023 Citigroup Inc.7,524$30K0.0%N/A0.033% 11/15/2023 Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266% 11/14/2023 Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101% 11/13/2023 FMR LLC2,830,284$11.15M0.0%N/A12.392% 11/7/2023 New York State Common Retirement Fund18,867$74K0.0%N/A0.083% (Data available from 1/1/2016 forward) TSBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TSBX shares? During the previous two years, 11 institutional investors and hedge funds held shares of Turnstone Biologics. The most heavily invested institutionals were Eventide Asset Management LLC ($2.79M), Sectoral Asset Management Inc. ($2.04M), PFM Health Sciences LP ($1.61M), FMR LLC ($653K), Point72 Asset Management L.P. ($519K), Zimmer Partners LP ($469K), and Caas Capital Management LP ($117K).Learn more on TSBX's institutional investors. What percentage of Turnstone Biologics stock is owned by institutional investors? 52.51% of Turnstone Biologics stock is owned by institutional investors. Learn more on TSBX's institutional investor holdings. Which institutional investors have been buying Turnstone Biologics stock? The following institutional investors have purchased Turnstone Biologics stock in the last 24 months: FMR LLC ($2.87M), Eventide Asset Management LLC ($708.32K), Sectoral Asset Management Inc. ($517.65K), Zimmer Partners LP ($130.83K), Kathleen S. Wright Associates Inc. ($42.55K), New York State Common Retirement Fund ($18.87K), and Sei Investments Co. ($11.88K). How much institutional buying is happening at Turnstone Biologics? Institutional investors have bought a total of 4,305,639 shares in the last 24 months. This purchase volume represents approximately $16.59M in transactions. Which Turnstone Biologics major shareholders have been selling company stock? The following institutional investors have sold Turnstone Biologics stock in the last 24 months: PFM Health Sciences LP ($891.40K), Point72 Asset Management L.P. ($251.66K), and Caas Capital Management LP ($30.68K). How much institutional selling is happening at Turnstone Biologics? Institutional investors have sold a total of 1,173,736 shares in the last 24 months. This volume of shares sold represents approximately $2.62M in transactions. Related Companies Dyadic International Institutional Ownership Gain Therapeutics Institutional Ownership Passage Bio Institutional Ownership Q32 Bio Institutional Ownership Rallybio Institutional Ownership ImmuCell Institutional Ownership CEL-SCI Institutional Ownership Achilles Therapeutics Institutional Ownership SCYNEXIS Institutional Ownership Actinium Pharmaceuticals Institutional Ownership This page (NASDAQ:TSBX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
